Beyond numbers: Public health insurance and oesophageal cancer mortality risk

Abstract

In this article, we comment on the work put forth by Wu et al regarding the investigation of oesophageal cancer-specific mortality for a cohort of patients from Chongqing University Cancer Hospital. We specifically focused on the implications of public health plans such as Urban Employee Basic Medical Insurance (UEBMI) and Urban Resident Basic Medical Insurance as well as out-of-pocket ratios on patient treatment plans regarding whether they pursue surgical interventions or therapeutic treatments such as chemotherapy. While Wu et al put forth potential explanations for why patients with the UEBMI plan surprisingly had a 23.30% increased risk of oesophageal cancer-specific death, more analysis is needed to alleviate cancer burden within this group. Although it is likely that patients covered by Urban Resident Basic Medical Insurance and higher out-of-pocket ratios have stronger self-recovery awareness, more work must be done to improve outcomes for people with the UEBMI plan while simultaneously implementing international and domestic initiatives to better emphasize cancer prevention and early detection. Lastly, future research must explore the relationship between Serious Illness Medical Insurance as well as the New Rural Cooperative Medical System on the mortality rate of oesophageal cancer patients in rural China, where disease burden is significantly higher than urban areas. By unifying these public health insurance schemes, officials can significantly alleviate economic burden of treatment and better prognosis for patients with oesophageal cancer.

Keywords: Urban Employee Basic Medical Insurance; Urban and Rural Basic Medical Insurance; Urban Resident Basic Medical; Insurance New Rural Cooperative Medical System; Oesophageal cancer; Public health insurance

Core Tip: Despite comprising a fifth of the global population, China carries approximately half of oesophageal cancer burden. With nearly the entire Chinese population covered by public health insurance plans, investigating the impact of insurance type, demographic features, and clinical aspects of treatment on patient mortality is critical to enacting measures to alleviate the economic burden and mortality rate of oesophageal cancer. Recent findings highlight the need for unifying and addressing inequities among these insurance plans while promoting oesophageal cancer prevention and detection. Future directions include analyzing the efficacy of insurance plans for rural Chinese communities which carry a disproportionate cancer burden.